<http://schema.org/description>
"Amgen reported positive data from a phase III trial on its PCSK9 inhibitor, evolocumab."^^<http://www.w3.org/2001/XMLSchema#string>
<https://www.zacks.com/stock/news/120810/amgen-reports-positive-evolocumab-data>